Reducing tobacco-related cancer incidence andmortality: Summary of an institute of medicine workshop

Oncologist

Volumn 19, Issue 1, 2014, Pages 21-31

  Balogh, Erin P ^a   Dresler, Carolyn ^b   Fleury, Mark E ^c   Gritz, Ellen R ^d   Kean, Thomas J ^e   Myers, Matthew L ^f   Nass, Sharyl J ^a   Nevidjon, Brenda ^g   Toll, Benjamin A ^h,i   Warren, Graham W ^j   Herbst, Roy S ^i,j  

^a INSTITUTE OF MEDICINE   (United States)

^b ARKANSAS DEPARTMENT OF HEALTH   (United States)

^c American Association for Cancer Research   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e C Change   (United States)

^f Campaign for Tobacco Free Kids   (United States)

^g DUKE UNIVERSITY   (United States)

^h YALE CANCER CENTER   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

Cancer; Tobacco cessation; Tobacco prevention and control; Tobacco use

Indexed keywords

CANCER; TOBACCO CESSATION; TOBACCO PREVENTION AND CONTROL; TOBACCO USE;

HUMANS; INCIDENCE; NEOPLASMS; SMOKING; SMOKING CESSATION; TOBACCO; UNITED STATES;

EID: 84892580079     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0230     Document Type: Article

References (89)

1. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008;57:1226-1228.
2. American Cancer Society. Cancer Facts & Figures 2012. Available at http://www.cancer. org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf. Accessed November 26, 2013.
3. Institute of Medicine. Reducing Tobacco-Related Cancer Incidence and Mortality:Workshop Summary. Washington, D.C.: The National Academies Press, 2012.
4. Centers for Disease Control and Prevention (CDC). Figure 8.1. Prevalence of Current Smoking Among Adults Aged 18 and Over: United States, 1997-2011. Available at http://www.cdc.gov/nchs/ data/nhis/earlyrelease/earlyrelease201206_08.pdf. Accessed November 26, 2013.
5. Centers for Disease Control and Prevention (CDC). Tobacco use-United States, 1900-1999. MMWR Morb Mortal Wkly Rep 1999;48:986-993.
6. Centers for Disease Control and Prevention (CDC). Current cigarette smoking prevalence among working adults-United States, 2004-2010. MMWR Morb Mortal Wkly Rep 2011;60:1305-1309.
7. Lasser K, Boyd JW, Woolhandler S et al. Smoking and mental illness: A population-based prevalence study. JAMA 2000;284:2606-2610.
8. Gierisch JM, Straits-Tröster K, Calhoun PS et al. TobaccouseamongIraq-andAfghanistan-eraveterans: A qualitative study of barriers, facilitators, and treatment preferences. Prev Chronic Dis 2012;9:E58.
9. Bray RM, Hourani LL. Substance use trends amongactive duty military personnel: Findings from the United States Department of Defense Health Related Behavior Surveys, 1980-2005. Addiction 2007;102:1092-1101.
10. HHS. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2012.
11. Giovino GA. The tobacco epidemic in the United States. Am J Prev Med 2007;33:S318-S326.
12. O'Connor RJ. Non-cigarette tobacco products: What havewelearnt and where areweheaded? Tob Control 2012;21:181-190.
13. Centers for Disease Control and Prevention (CDC). Consumption of cigarettes and combustible tobacco-United States, 2000-2011. MMWR Morb Mortal Wkly Rep 2012;61:565-569.
14. HHS. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
15. Secretan B, Straif K, Baan R et al. A review of human carcinogens-Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033-1034.
16. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC monographs on the evalution of carcinogenic risks to humans. Tobacco Smoke and Involuntary Smoking. Vol 83. Lyon, France: IARC, 2004.
17. IARC. World Cancer Report 2008. Lyon, France: IARC, 2008.
18. Yu GP, Ostroff JS, Zhang ZF et al. Smoking history and cancer patient survival: A hospital cancer registry study. Cancer Detect Prev 1997;21:497-509.
19. Kvale E, Ekundayo OJ, Zhang Y et al. History of cancer and mortality in community-dwelling older adults. Cancer Epidemiol 2011;35:30-36.
20. Warren GW, Kasza KA, Reid ME et al. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013;132:401-410.
21. Gajdos C, Hawn MT, Campagna EJ et al. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol 2012;19: 1430-1438.
22. Gillison ML, Zhang Q, Jordan R et al. Tobacco smokingandincreasedriskofdeathandprogression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012;30:2102-2111.
23. Richards CH, Platt JJ, Anderson JH et al. The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg 2011;254:83-89.
24. Kenfield SA, Stampfer MJ, Chan JM et al. Smoking and prostate cancer survival and recurrence. JAMA 2011;305:2548-2555.
25. Waggoner SE, Darcy KM, Fuhrman B et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study. Gynecol Oncol 2006;103:853-858.
26. Kenfield SA, Stampfer MJ, Rosner BA et al. Smoking and smoking cessation in relation to mortality in women. JAMA 2008;299:2037-2047.
27. BittnerN, MerrickGS, GalbreathRWetal. Primary causes of death after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2008;72:433-440.
28. Li CI, Daling JR, Porter PL et al. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptorpositive invasive breast cancer. J Clin Oncol 2009;27: 5312-5318.
29. Park SM, Lim MK, Jung KW et al. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol 2007;25:4835-4843.
30. van den Belt-Dusebout AW, de Wit R, Gietema JA et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 2007;25:4370-4378.
31. Travis LB, Gospodarowicz M, Curtis RE et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002;94:182-192.
32. Obedian E, Fischer DB, Haffty BG. Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 2000;18:2406-2412.
33. Hooning MJ, Botma A, Aleman BM et al. Longterm risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 2007;99:365-375.
34. Wright CD, Kucharczuk JC, O'Brien SM et al. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustmentmodel. J Thorac Cardiovasc Surg 2009; 137:587-595; discussion 596.
35. Cooke DT, Lin GC, Lau CL et al. Analysis of cervical esophagogastric anastomotic leaks after transhiatal esophagectomy: Risk factors, presentation, and detection. Ann Thorac Surg 2009;88: 177-184; discussion 184-185.
36. Land SR, Cronin WM, Wickerham DL et al. Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial. Cancer Prev Res 2011;4:1393-1400.
37. Weaver KE, Rowland JH, Augustson E et al. Smoking concordance in lung and colorectal cancer patient-caregiver dyads and quality of life. Cancer Epidemiol Biomarkers Prev 2011;20:239-248.
38. Jang S, Prizment A, HaddadT et al. Smokingand quality of life among female survivors of breast, colorectal and endometrial cancers in a prospective cohort study. J Cancer Surviv 2011;5:115-122.
39. Khuri FR, Kim ES, Lee JJ et al. The impact of smoking status, disease stage, and index tumor site on secondprimary tumorincidenceandtumorrecurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001;10:823-829.
40. Warren GW, Arnold SM, Valentino JP et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol 2012;103:45-48.
41. MarinVP, Pytynia KB, LangsteinHNet al. Serum cotinine concentration andwound complications in head and neck reconstruction. Plast Reconstr Surg 2008;121:451-457.
42. Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl JMed 2010;363:24-35.
43. Dahlstrom KR, Calzada G, Hanby JD et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: A staging system in need of repair. Cancer 2013;119:81-89.
44. Jerjes W, Upile T, Radhi H et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: Short communication. Head Neck Oncol 2012;4:6.
45. Phipps AI, Baron J, NewcombPA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: The Seattle Colon Cancer Family Registry. Cancer 2011;117:4948-4957.
46. BrowmanGP, Wong G, Hodson I et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328:159-163.
47. Joshu CE, Mondul AM, Meinhold CL et al. Cigarettesmokingandprostate cancer recurrenceafter prostatectomy. J Natl Cancer Inst 2011;103:835-838.
48. Bjarnason GA, Mackenzie RG, Nabid A et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys 2009;73:166-172.
49. Cooley ME, Sarna L, Kotlerman J et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer 2009;66:218-225.
50. Gritz ER, Lam CY, Vidrine DJ et al. Cancer prevention: Tobacco dependence and its treatment. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Philadelphia, PA: Wolters Kluwer Lippincott Williams & Wilkins, 2011:529-542.
51. Tseng TS, Lin HY, Moody-Thomas S et al. Who tended to continue smoking after cancer diagnosis: The national health and nutrition examination survey 1999-2008. BMC Public Health 2012;12:784.
52. Walker MS, Vidrine DJ, Gritz ER et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2370-2377.
53. Cooley ME, Finn KT, Wang Q et al. Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their familymembers: A pilot study. Cancer Nurs 2013;36:145-154.
54. Bottorff JL, Robinson CA, Sullivan KM et al. Continued family smoking after lung cancer diagnosis: The patient's perspective. Oncol Nurs Forum 2009;36:E126-E132.
55. Centers for Disease Control and Prevention (CDC). Quitting smoking among adults-United States, 2001-2010. MMWR Morb Mortal Wkly Rep 2011;60:1513-1519.
56. Fiore MC, Jaen CR, Baker TB et al. Treating Tobacco use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, 2008.
57. Legacy: Ex. A New Way to Think About Quitting Smoking. Available at http://www.becomeanex. org/about-ex.php#. Accessed November 26, 2013.
58. Schroeder SA. What to do with a patient who smokes. JAMA 2005;294:482-487.
59. Peters EN, Torres E, Toll BA et al. Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Programclinical trials. J Clin Oncol 2012;30:2869-2875.
60. Warren GW, Peters EN, Torres E et al. Tobacco assessment in actively accruing Cooperative Group clinical trials. Cancer Res 72: 2012 (suppl; abstr 648)
61. Goldstein AO, Ripley-Moffitt CE, Pathman DE et al. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res 2013;15:52-58.
62. U.S. Department of Health and Human Services. Ending the tobacco epidemic: A tobacco control strategic action plan for the U.S. Department of Health and Human Services. Washington, DC: Office of the Assistant Secretary for Health, 2010.
63. Bayer R, Gostin L, Marcus-Toll D. Repackaging cigarettes-will the courts thwart the FDA? N Engl J Med 2012;367:2065-2067.
64. Dennis B. Government Quits Legal Battle Over Graphic Cigarette Warnings. Available at http://www.washingtonpost.com/national/healthscience/ government-quits-legal-battle-over-graphiccigarette-warnings/2013/03/19/23053ccc-90d7-11e2-bdea-e32ad90da239_story.html. Accessed April 4, 2013.
65. Koh HK, Sebelius KG. Promoting prevention through the Affordable Care Act. NEngl JMed 2010; 363:1296-1299.
66. Ellis JA, Perl SB, Frieden TR et al. Decline in smoking prevalence-New York City, 2002-2006. MMWR Morb Mortal Wkly Rep 2007;56:604-608.
67. New York City Department of Health and Mental Hygiene. 2012. Youth Risk Behavior Survey. Available at https://a816-healthpsi.nyc.gov/SASStoredProcess/ guest?_PROGRAM5%2FEpiQuery% 2FYRBS%2Fyrbsindex. Accessed November 26, 2013.
68. Land T, Rigotti NA, Levy DE et al. A longitudinal studyof medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease. PLoS Med 2010;7:e1000375.
69. Richard P, West K, Ku L. The return on investment of a Medicaid tobacco cessation program in Massachusetts. PLoS One 2012;7:e29665.
70. National Cancer Institute. Tobacco Control Monograph 19: The Role of the Media in Promoting and Reducing Tobacco Use. Available at http:// cancercontrol.cancer.gov/brp/tcrb/monographs/19/ index.html. Accessed November 26, 2013.
71. Farrelly MC, Nonnemaker J, Davis KC et al. The Influence of the National truth campaign on smoking initiation. AmJ Prev Med 2009;36:379-384.
72. Vallone DM, Duke JC, Cullen J et al. Evaluation of EX: A national mass media smoking cessation campaign. Am J Public Health 2011;101:302-309.
73. Vallone DM, Niederdeppe J, Richardson AK et al. A national mass media smoking cessation campaign: Effects by race/ethnicity and education. Am J Health Promot 2011;25:S38-S50.
74. Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. Lancet 2010;376:1261-1271.
75. Farrelly MC, Davis KC, Haviland ML et al. Evidence of a dose-response relationship between "truth" antismoking ads and youth smoking prevalence. Am J Public Health 2005;95:425-431.
76. Prokhorov AV, Kelder SH, Shegog R et al. Impact of A Smoking Prevention Interactive Experience (ASPIRE), an interactive, multimedia smoking prevention and cessation curriculum for culturally diverse high-school students. Nicotine Tob Res 2008;10:1477-1485.
77. Prokhorov AV, Hudmon KS, Marani S et al. Engaging physicians and pharmacists in providing smoking cessation counseling. Arch Intern Med 2010;170:1640-1646.
78. Raiff BR, Jarvis BP, Rapoza D. Prevalence of video game use, cigarette smoking, and acceptability of a video game-based smoking cessation intervention among online adults. Nicotine Tob Res 2012;14:1453-1457.
79. Free C, Knight R, Robertson S et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): A single-blind, randomised trial. Lancet 2011;378:49-55.
80. Morgan G, Schnoll RA, Alfano CM et al. National Cancer Institute conference on treating tobaccodependence atcancer centers. J Oncol Pract 2011;7:178-182.
81. Oncology Nursing Society. Nursing Leadership in Global and Domestic Tobacco Control. Available at http://www.ons.org/Publications/Positions/ Tobacco. Accessed November 26, 2013.
82. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: Tobacco control-reducing cancer incidence and saving lives: 2003. J Clin Oncol 2003;21: 2777-2786.
83. Toll BA, Brandon TH, Gritz ER et al. Assessing tobacco use by cancer patients and facilitating cessation: An American Association for Cancer Research policy statement. Clin Cancer Res 2013; 19:1941-1948.
84. C-Change. Risk Reduction. Promoting a National Shift to Cancer Risk Reduction (Prevention and Early Detection). Available at http://c-changetogether. org/risk-reduction. Accessed November 26, 2013.
85. Campaign for Tobacco-Free Kids. Spending vs. Tobacco Company Marketing. Available at http://www. tobaccofreekids.org/research/factsheets/pdf/0201. pdf. Accessed November 26, 2013.
86. Centers for Disease Control and Prevention (CDC). State tobacco revenues compared with tobacco control appropriations-United States, 1998-2010. MMWR Morb Mortal Wkly Rep 2012; 61:370-374.
87. Campaign for Tobacco-Free Kids. Broken Promises to Our Children. Available at http://www. tobaccofreekids.org/what_we_do/state_local/ tobacco_settlement/. Accessed November 26, 2013.
88. Conroy MB, Majchrzak NE, Silverman CB et al. Measuring provider adherence to tobacco treatment guidelines: A comparison of electronic medical record review, patient survey, and provider survey. Nicotine Tob Res 2005;7(suppl 1):S35-S43.
89. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: Ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:2287-2293.